Delivery Order SPE2DB22D2103-SPE2DB24FR9QE
Award Date 7/8/24
Potential Completion Date 7/29/24
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The firm-fixed-price contract, valued at $14,260.08, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 18, 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
- This federal contract award is for the delivery of the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA). The $1,188.34 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 14, 2024, with a completion date of September 5, 2024. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- This federal contract award is for the delivery of pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML to the Defense Logistics Agency (DLA), a defense agency. The $7,376.46 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 10, 2025, with a performance period extending through July 2, 2025. The contract is not designated as a set-aside and is therefore open to full and open competition....
- This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $9,835.28 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 20, 2025, with a completion date of July 14, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $22,129.38 and runs through April 9, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,188.34, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating it was an open competition. The award includes an Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in a non-set-aside, competitive award with a firm fixed price. The contract has a ceiling value of $1,229.41 and an ultimate completion date of August 6, 2025. Amerisourcebergen Drug Corp holds a significant...
- The federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The total ceiling value of the contract is $4,753.36. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024, with a period of performance through December 6, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Firm Fixed Price Delivery Order with a ceiling value of $2,458.82 and an ultimate completion date of January 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $7,376.46. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a pharmaceutical product, with a period of performance through June 9, 2025. This appears to be a non-set-aside contract, meaning it was open to...